Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154567 · ClinicalTrials.gov registry record · Phase 1
Effects of Stress and Drug-cue Exposure (SCM)
A Phase 1 study, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03154567 is a Phase 1 study that has completed, run by Wayne State University. The registered enrollment target is 12 participants.
The verdict
NCT03154567, a Phase 1 study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of the proposed study to examine the links among stress, craving for marijuana, and marijuana reminders, or "cues". In this study, an agent called yohimbine will be used to produce stress-like responses. Yohimbine is known to cause stress response in studies of alcohol and other substance use disorders. This study intends to show it can be used to cause stress in marijuana users as well.
Interventions
- DRUG Yohimbine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2023-10-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03154567
The ClinicalTrials.gov registry entry for NCT03154567 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Yohimbine is the first listed.
NCT03154567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03154567 about?
NCT03154567 is a clinical study titled "Effects of Stress and Drug-cue Exposure (SCM)". The purpose of the proposed study to examine the links among stress, craving for marijuana, and marijuana reminders, or "cues". In this study, an agent called yohimbine will be used to produce stress-like responses. Yohimbine is known to cause stress response in studies of alcohol and other substan...
What is the current status of trial NCT03154567?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2017-11-01. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT03154567?
The interventions under investigation include: Yohimbine (DRUG).
Who is sponsoring clinical trial NCT03154567?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.